Levine James E. 4
4 · Cardiff Oncology, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-09-16$1.56/sh+30,000$46,710→ 60,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.555 to $1.56. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.